MediWound (MDWD) Cash & Equivalents (2013 - 2026)

MediWound's Cash & Equivalents history runs 13 years deep, the most recent figure standing at $48.3 million for Q4 2025.

• In Q4 2025, Cash & Equivalents rose 42.15% year-over-year to $48.3 million; the TTM figure through Dec 2025 stood at $48.3 million (up 42.15% YoY), while the FY2025 annual figure was $48.3 million, up 42.15% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $48.3 million, down from $59.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $59.1 million in Q3 2025, with the low at $9.2 million in Q1 2025.
• The 5-year median for Cash & Equivalents is $17.2 million (2021), against an average of $26.5 million.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents soared 206.85% in 2022, then slumped 76.74% in 2024.
• MediWound's Cash & Equivalents stood at $11.0 million in 2021, then jumped by 206.85% to $33.9 million in 2022, then plunged by 64.99% to $11.9 million in 2023, then soared by 186.58% to $34.0 million in 2024, then surged by 42.15% to $48.3 million in 2025.
• Business Quant data shows MDWD's Cash & Equivalents at $48.3 million in Q4 2025, $59.1 million in Q3 2025, and $9.2 million in Q2 2025.